King Pharmaceuticals will cut 20% of its 2,600 employee workforce after a federal appeals court judge ruled against a patent extension on the company's blood pressure treatment Altace.
Most of the 520 layoffs will come from the Bristol, TN-based company's field sales force, King spokesman James Green told a local newspaper, The Bristol Herald Courier.
"Most of these reductions are going to our field sales force," Green said. "Those are our people that go to see doctors and tell them the benefits of our products. They are located all across the country."
Green added, "All of those will receive 60-day notices and an array of benefits, including severance [pay] and health care."
Green said about 50 jobs "general and administrative" positions will be slashed in Bristol. He told The Courier that individual managers were given the discretion to decide who would be laid off.
More
No comments:
Post a Comment